Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 2B (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 104 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to 5-HT2B receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 7 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 195 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to 5-HT7 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sigma non-opioid intracellular receptor 1 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 220 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to sigma1 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 257 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to 5-HT2A receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-1A adrenergic receptor (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 286 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to adrenergic alpha 1A receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-1D adrenergic receptor (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 293 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to adrenergic alpha 1D receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2A adrenergic receptor (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 407 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to adrenergic alpha 2A receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2C adrenergic receptor (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 446 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to adrenergic alpha 2C receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to cannabinoid CB1 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to cannabinoid CB2 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A1 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to adenosine A1 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Somatostatin receptor type 2 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to SST2 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Somatostatin receptor type 4 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to SST4 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A2a (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to adenosine A2A receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM50445614 (CHEMBL3104093) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Missouri Curated by ChEMBL | Assay Description Binding affinity to adenosine A3 receptor (unknown origin) | Bioorg Med Chem Lett 24: 3088-91 (2014) Article DOI: 10.1016/j.bmcl.2014.05.016 BindingDB Entry DOI: 10.7270/Q28K7BQ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141416 (US10668051, Compound Example 67 | US8921364, 67) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20.4 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141416 (US10668051, Compound Example 67 | US8921364, 67) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20.4 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141426 (US10668051, Compound Example 84 | US8921364, 84) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20.8 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141426 (US10668051, Compound Example 84 | US8921364, 84) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20.8 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141438 (US10668051, Compound Example 104 | US8921364, 104) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 23.0 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141438 (US10668051, Compound Example 104 | US8921364, 104) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141428 (US10668051, Compound Example 87 | US8921364, 87) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 32.6 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141428 (US10668051, Compound Example 87 | US8921364, 87) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 32.6 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141421 (US10668051, Compound Example 78 | US8921364, 78) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34.1 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141421 (US10668051, Compound Example 78 | US8921364, 78) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34.1 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141424 (US10668051, Compound Example 82 | US8921364, 82) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35.7 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141424 (US10668051, Compound Example 82 | US8921364, 82) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35.7 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141396 (US10668051, Compound Example 7 | US8921364, 7) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 36.4 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141396 (US10668051, Compound Example 7 | US8921364, 7) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 36.4 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141444 (US10668051, Compound Example 114 | US8921364, 114) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 37.6 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141444 (US10668051, Compound Example 114 | US8921364, 114) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 37.6 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM152937 (US8993612, 20) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 39.2 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8993612 (2015) BindingDB Entry DOI: 10.7270/Q2CN72NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141442 (US10668051, Compound Example 111 | US8921364, 111) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 47.2 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141442 (US10668051, Compound Example 111 | US8921364, 111) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 47.2 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141419 (US10668051, Compound Example 74 | US8921364, 74) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141419 (US10668051, Compound Example 74 | US8921364, 74) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 48.0 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141425 (US10668051, Compound Example 83 | US8921364, 83) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 48.2 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141425 (US10668051, Compound Example 83 | US8921364, 83) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 48.2 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141418 (US10668051, Compound Example 72 | US8921364, 72) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 48.2 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141418 (US10668051, Compound Example 72 | US8921364, 72) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 48.2 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141441 (US10668051, Compound Example 108 | US8921364, 108) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50.6 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141441 (US10668051, Compound Example 108 | US8921364, 108) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50.6 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM152932 (US8993612, 6) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 51.3 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8993612 (2015) BindingDB Entry DOI: 10.7270/Q2CN72NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141448 (US10668051, Compound Example 126 | US8921364, 126) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 52.6 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141448 (US10668051, Compound Example 126 | US8921364, 126) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 52.6 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM152936 (US8993612, 18) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 53.4 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8993612 (2015) BindingDB Entry DOI: 10.7270/Q2CN72NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141439 (US10668051, Compound Example 106 | US8921364, 106) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141439 (US10668051, Compound Example 106 | US8921364, 106) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141402 (US10668051, Compound Example 28 | US8921364, 28) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60.3 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) BindingDB Entry DOI: 10.7270/Q2V40Z7G | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141402 (US10668051, Compound Example 28 | US8921364, 28) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60.3 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 137 total ) | Next | Last >> |